Novotech, a global full-service clinical contract research organisation (CRO), has been awarded the 2024 Global Company of the Year Award by Frost & Sullivan. This award recognises the company’s ability to drive innovation in clinical development, offer advanced technological solutions,
Synexa Life Sciences, a specialist in biomarker and bioanalysis services, has announced the acquisition of Alderley Analytical Ltd, an independent Contract Research Organisation (CRO). The acquisition took place recently, with Alderley Analytical now operating from its state-of-the-art GLP/GCP-accredited laboratory near
Franklin Biolabs, headquartered in Philadelphia, has officially launched its operations, marking a significant entry into the genetic medicines sector. Founded by Dr. James Wilson, a renowned figure in gene therapy, the organisation is designed to provide comprehensive solutions from discovery
Moffitt Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute, announced its collaboration with CMIC. The partnership aims to facilitate cross-border clinical trials for new therapies, increasing participant diversity. Under the agreement, Moffitt will act as the
Emmes Group, a global contract research and technology organisation, has been acknowledged as a Major Contender in the Everest Group’s recently published ‘Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment 2024.’ This recognition is attributed to the capabilities
RSSL, a contract research organisation (CRO) specialising in food and life sciences, has announced the opening of a new laboratory dedicated to advanced 3D imaging and metrology services. The £700,000 investment supports the growing demand for high-precision imaging and measurement
Gentronix, a contract research organisation (CRO) based in the UK and focused on genetic toxicology, has been acquired by Denmark’s Scantox Group for an undisclosed sum. The deal marks a significant exit for Mercia Ventures’ Northern Venture Capital Trusts (VCTs),
Halia Therapeutics, Inc. has entered a strategic collaboration with Southern Star Research Pty Ltd, an Australian contract research organisation (CRO), to launch a Phase 1 clinical trial for its LRRK2 inhibitor, HT-4253. This collaboration signifies a crucial step in the
Sanyou Biopharmaceuticals has introduced a comprehensive product line aimed at advancing monkeypox research and treatment development. The product range, consisting of 65 items, includes natural epitope antigens, high-affinity monoclonal antibodies, and overexpression cell lines, all designed to target key sites
Avance Clinical, a contract research organization (CRO) specializing in biotech, has been awarded the 2024 Global Customer Value Leadership Award by Frost & Sullivan. This recognition underscores the company’s commitment to delivering high-quality clinical trials and its strong focus on
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
